Home › Studies › PRJNA1199756
PRJNA1199756 SRP555672

Mangiferin gut metabolism in healthy and IBD adults, Belgium

Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism

48 fecal samples from adults in Belgium, including healthy controls and individuals with IBD, in an intervention study of dietary mangiferin supplementation and its microbial conversion to norathyriol. machine-written summary

48 samples · 48 runs · BE · Adult · 2025 · 13.34 Gbp / sample

Sources
✓Sequence archive 288○Abstract / description✓Full text 48○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive288 sample values (collection date, country, health condition, health condition detail, subject id, timepoint)
○ Abstract / descriptionread; no usable statement
✓ Full text48 sample values (antibiotic exposure) · PMC12101588
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention — arms not resolved

Non-microbial dietary supplement (vitamins design single_arm_before_after · population healthy_control · Mangiferin oral treatment in healthy adult volunteers

“fecal samples from healthy adult volunteers treated with MAN” — abstract:40401774 (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult48
Condition
healthy_control30
ibd_unspecified18
Country
BE48
Body site
primary48
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)all projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 48 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 13.34 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

12 of 12 people sampled more than once (48 samples; median 4, up to 5 per person) · follow-up median 1 d (max 1 d) · median interval between samples 1 d (time from timepoint labels).

IBD Patient1IBD Patient1: day 0IBD Patient1: day 1IBD Patient1: day 1IBD Patient2IBD Patient2: day 0IBD Patient2: day 1IBD Patient2: day 1IBD Patient3IBD Patient3: day 0IBD Patient3: day 1IBD Patient3: day 1IBD Patient4IBD Patient4: day 0IBD Patient4: day 1IBD Patient4: day 1IBD Patient5IBD Patient5: day 0IBD Patient5: day 1IBD Patient5: day 1IBD Patient6IBD Patient6: day 0IBD Patient6: day 1IBD Patient6: day 1Well human adultWell human adult1: day 0Well human adult1: day 1Well human adult1: day 1Well human adult1: day 1Well human adult1: day 1Well human adultWell human adult2: day 0Well human adult2: day 1Well human adult2: day 1Well human adult2: day 1Well human adult2: day 1Well human adultWell human adult3: day 0Well human adult3: day 1Well human adult3: day 1Well human adult3: day 1Well human adult3: day 1Well human adultWell human adult4: day 0Well human adult4: day 1Well human adult4: day 1Well human adult4: day 1Well human adult4: day 1Well human adultWell human adult5: day 0Well human adult5: day 1Well human adult5: day 1Well human adult5: day 1Well human adult5: day 1Well human adultWell human adult6: day 0Well human adult6: day 1Well human adult6: day 1Well human adult6: day 1Well human adult6: day 10 d0 d0 d1 d1 d

Each row is one person (12 shown); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 23.1%Phocaeicola 9.7%Faecalibacterium 7.8%Prevotella 6.8%Alistipes 4.5%Parabacteroides 3.8%Roseburia 2.7%Megamonas 1.9%Sutterella 1.6%Hominicoprocola 1.5%Escherichia 1.4%Lachnospira 1.3%not assigned to a genus 3.1%other genera 30.8%

Genera, mean relative abundance over 46 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category48 100%
country48 100%48
health_condition48 100%48
subject_id48 100%48
antibiotic_exposure48 100%48
collection_date48 100%48
health_condition_detail48 100%48
timepoint_label48 100%48
Papers (1)
  • Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism. 2025 PMID 40401774 PMC12101588 own_data
Details
Archive description

Mangiferin (MAN) is a natural C-glycosylxanthone predominantly found in various plant species, most notably, in the leaves, stems, bark, and fruits of Mangifera indica (mango tree). Although C-glycosides are generally more metabolically stable, evidence suggests that bacterial enzymes, can deglycosylate them. Overall, our study provides new insights into the microbial metabolism of MAN. While MAN itself exhibited limited metabolic effects, its microbial conversion to the aglycone NOR, potentially mediated by specific gut bacteria such as CAKRHR01 sp934339005 and Enterococcus sp900549885, may explain some of the bioactive properties attributed to MAN.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “Gut microbiota-mediated conversion of”
  • body site study.description · “mediated by specific gut bacteria such as”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN46118931antibiotic_exposurenoR30.70paper.fulltext.methodsno antibiotic use in the past 3 months
SAMN46118931collection_date2024R10.90biosample.attribute:collection_date2024
SAMN46118931countryBER10.90sample.attr.geo_loc_nameBelgium: not further specified
SAMN46118931health_conditionibd_unspecifiedR10.85biosample_attrIBD Patient
SAMN46118931health_condition_detailIBD PatientR10.90sample.attr.host_diseaseIBD Patient
SAMN46118931subject_idIBD Patient1R10.85sample.attr.host_subject_idIBD Patient1
SAMN46118931timepoint_label0hR10.85sample.attr.timepoint0h
Sequencing

48 runs over 48 samples · mean 13.79 Gbp per run (median 13.34 Gbp, total 662.14 Gbp; 48 runs with a base count) · layout PAIRED 48 · platform ILLUMINA 48 · models Illumina NovaSeq X Plus (48) · 96% of runs with a Sandpiper profile · first public 2025-08-26

Authors (4)

Bunt D first · Schwalbe M · Hayeeawaema F · El Aidy S last

Downloads

PRJNA1199756.csv.gz (2.1 KB) · parquet (71.2 KB) — all 48 samples, every field with route and confidence · PRJNA1199756_determinations.csv.gz (2.3 KB) — 336 evidence rows

Samples (48 · every field this project has values for · hover a cell for its source)
Loading the sample table…